维普中文期刊产品整合服务
23篇 您的检索式:作者名="Savin MA"
    题名 作者 年代 出处 被引量
1Growth suppression of hmnan leukemic cells in vitro by ascorbic cacid显示文摘Park CH Amare M Savin MA 1980Cancer Res1980,40,:1
2Placement of vena cava filters:Factors affecting technical success and immediate complications显示文摘 Panicker HK Sadiq S 2002Am J Roentgenol2002,179,:1
3Phase Ⅱ study of weekly albumin-bound paclitaxel for patients with metastatic breast cancerheavily pretreated with taxanea显示文摘Blum JL Savin MA Edelman G 2007Clin Breast Cancer2007,7,11:1
4Aduvant Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyelophosphamide as adjuvant therapy for operable breast eaneer显示文摘Jones SE Savin MA Holmes FA 2006Clin Oncol2006,24,:1
5PhaseⅢtrial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
6Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophos- phamide as adjuvant therapy for operable breast cancer显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
7Phase Ⅱ study of weekly albumin-bound Paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes显示文摘Blum JL Savin MA Edelman G 2007Clin Breast Cancer2007,7,11:1
8Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophos- phamide as adjuvant therapy for operable breast cancer显示文摘Jones SE Savin MA Holmes FA ct al 2006J Clin Oncol2006,24,34:1
9Phase II study ofweekly albumin-bound paclitaxel for patients with metastaticbreast cancer heavily pretreated with taxanes 显示文摘Blum JL Savin MA Edelman G 2007Clin BreastCancer2007,7,11:1
10Phase Ⅱ study of weekly albumin-bound paclitaxel for patients with metastatic breast cancer heavily pretreated with taxanes显示文摘Blum JL Savin MA Edelman G 0,,11:1
11Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
12Phase III trim comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclo- phosphamide as adjuvant therapy for operable breast cancer显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
13Growth Suppression of human leukemic cells in vitro by L-ascorbic acid 显示文摘Park CH Amare M Savin MA 1980Cancer Res1980,40,8:1
14Phase II stud- y of weekly albumin-bound paclkaxel for patients with metastatic breast cancer heavily pretreated with taxanes显示文摘BIum JL Savin MA Edelman G 2007Clin Breast Cancer2007,7,11:1
15Plactment of vena cava filters:factors affecting technical success and immediate complications显示文摘Savin MA Panicker HK Sadiq S 2002AJR2002,179,30:1
16Phase Ⅲ trial comparing Doxorubicin plus Cyclophosphamide with Docetaxel plus Cyclophosphamide as adjuvant therapy for operable breast cancer 显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
17Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer 显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
18Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oncol2006,24,34:1
19Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophos- phamide as adjuvant therapy for operable breast cancer 显示文摘Jones SE Savin MA Holmes FA 2006J Clin Oneol2006,24,34:1
20Phase Ⅲ trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjnvant therapy for operable breast cancer 显示文摘Jones SE Savin MA Hohnes FA 2006J Clin Oncol2006,24,34:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费